Literature DB >> 12936989

Epidemiological risk factors for isolation of ceftriaxone-resistant versus -susceptible citrobacter freundii in hospitalized patients.

Peter W Kim1, Anthony D Harris, Mary-Claire Roghmann, J Glenn Morris, Arjun Strinivasan, Eli N Perencevich.   

Abstract

Antimicrobial resistance is an emerging problem among nosocomial bacteria. Risk factors for the recovery of ceftriaxone-resistant (CRCF) or -susceptible (CSCF) Citrobacter freundii in clinical cultures from hospitalized patients were determined by using a case-case-control study design. CRCF was isolated from 43 patients (case group 1) and CSCF was isolated from 87 patients (case group 2) over a 3-year period. Risk factors for CRCF were exposure to imipenem (odds ratio [OR], 7.5; 95% confidence interval [CI], 1.2 to 45.4), broad-spectrum cephalosporins (OR, 6.9; 95% CI, 1.8 to 26.7), vancomycin (OR, 3.0; 95% CI, 1.2 to 7.4), or piperacillin-tazobactam (OR, 2.6; 95% CI, 1.1 to 6.2), as well as hospital length of stay >or=1 week (OR, 3.6; 95% CI, 1.3 to 10.2) and intensive care unit (ICU) stay (OR, 2.6; 95% CI, 1.1 to 6.2). Risk factors for CSCF were peripheral vascular disease (OR, 23.2; 95% CI, 4.3 to 124.6), AIDS (OR, 9.5; 95% CI, 1.6 to 55.5), cerebrovascular disease (OR, 4.2; 95% CI, 1.6 to 10.8), and ICU stay (OR, 3.1; 95% CI, 1.8 to 5.4).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12936989      PMCID: PMC182594          DOI: 10.1128/AAC.47.9.2882-2887.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  43 in total

Review 1.  Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review.

Authors:  A D Harris; T B Karchmer; Y Carmeli; M H Samore
Journal:  Clin Infect Dis       Date:  2001-03-21       Impact factor: 9.079

Review 2.  Compliance with hand disinfection and its impact on hospital-acquired infections.

Authors:  D Pittet
Journal:  J Hosp Infect       Date:  2001-08       Impact factor: 3.926

3.  Gram-negative bacillary meningitis in adult post-neurosurgical patients.

Authors:  C H Lu; W N Chang; Y C Chuang; H W Chang
Journal:  Surg Neurol       Date:  1999-11

4.  Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients.

Authors:  Anthony D Harris; David Smith; Judith A Johnson; Douglas D Bradham; Mary-Claire Roghmann
Journal:  Clin Infect Dis       Date:  2001-12-26       Impact factor: 9.079

5.  Bacteremias due to Citrobacter diversus and Citrobacter freundii. Incidence, risk factors, and clinical outcome.

Authors:  V Drelichman; J D Band
Journal:  Arch Intern Med       Date:  1985-10

6.  Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.

Authors:  H Knothe; P Shah; V Krcmery; M Antal; S Mitsuhashi
Journal:  Infection       Date:  1983 Nov-Dec       Impact factor: 3.553

7.  Clinical significance of citrobacter isolates.

Authors:  G R Hodges; C E Degener; W G Barnes
Journal:  Am J Clin Pathol       Date:  1978-07       Impact factor: 2.493

8.  Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System.

Authors:  D R Burwen; S N Banerjee; R P Gaynes
Journal:  J Infect Dis       Date:  1994-12       Impact factor: 5.226

Review 9.  Citrobacter infections in humans: experience at the Seattle Veterans Administration Medical Center and a review of the literature.

Authors:  B A Lipsky; E W Hook; A A Smith; J J Plorde
Journal:  Rev Infect Dis       Date:  1980 Sep-Oct

10.  Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy.

Authors:  J W Chow; M J Fine; D M Shlaes; J P Quinn; D C Hooper; M P Johnson; R Ramphal; M M Wagener; D K Miyashiro; V L Yu
Journal:  Ann Intern Med       Date:  1991-10-15       Impact factor: 25.391

View more
  12 in total

1.  Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa.

Authors:  Keith S Kaye; Zeina A Kanafani; Ashley E Dodds; John J Engemann; Stephen G Weber; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

2.  Clinical and molecular epidemiology of multidrug-resistant Citrobacter spp. infections in a French university hospital.

Authors:  J-P Lavigne; C Defez; N Bouziges; A Mahamat; A Sotto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-06       Impact factor: 3.267

Review 3.  Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance.

Authors:  Vered Schechner; Elizabeth Temkin; Stephan Harbarth; Yehuda Carmeli; Mitchell J Schwaber
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

4.  Impact of empiric antibiotic therapy on outcomes in patients with Pseudomonas aeruginosa bacteremia.

Authors:  Regina B Osih; Jessina C McGregor; Shayna E Rich; Anita C Moore; Jon P Furuno; Eli N Perencevich; Anthony D Harris
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

5.  Multidrug resistant citrobacter: an unusual cause of liver abscess.

Authors:  Prabhat Kumar; Soumik Ghosh; Deepak Rath; A K Gadpayle
Journal:  BMJ Case Rep       Date:  2013-04-22

6.  Morphological alterations on Citrobacter freundii bacteria induced by erythrosine dye and laser light.

Authors:  Josmary R Silva; Gleidson Cardoso; Rafael R G Maciel; Nara C de Souza
Journal:  Lasers Med Sci       Date:  2013-08-24       Impact factor: 3.161

7.  Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci co-colonization.

Authors:  Jon P Furuno; Eli N Perencevich; Judith A Johnson; Marc-Oliver Wright; Jessina C McGregor; J Glenn Morris; Sandra M Strauss; Mary-Claire Roghman; Lucia L Nemoy; Harold C Standiford; Joan N Hebden; Anthony D Harris
Journal:  Emerg Infect Dis       Date:  2005-10       Impact factor: 6.883

8.  Complete Genome of Citrobacter freundii Siphophage Stevie.

Authors:  Justin P Shaw; Carlos A Aviles Medina; Yi Chen; Adrian J Luna; Adriana C Hernandez; Gabriel F Kuty Everett
Journal:  Genome Announc       Date:  2015-02-05

9.  Effects of reducing beta-lactam antibiotic pressure on intestinal colonization of antibiotic-resistant gram-negative bacteria.

Authors:  Saskia Nijssen; Ad Fluit; David van de Vijver; Janetta Top; Rob Willems; Marc J M Bonten
Journal:  Intensive Care Med       Date:  2010-03       Impact factor: 17.440

10.  An Analysis of the Effects of Vancomycin and/or Vancomycin-Resistant Citrobacter freundii Exposure on the Microbial Community Structure in Soil.

Authors:  Mariusz Cycoń; Sławomir Borymski; Kamila Orlewska; Tomasz J Wąsik; Zofia Piotrowska-Seget
Journal:  Front Microbiol       Date:  2016-06-28       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.